← Back to front page
Asia · Regional markets · Korea Economic Daily

Alteogen clears US patent hurdle as Merck wins all 14 challenges vs Halozyme

Published by Korea Economic Daily · South Korea 20 h ago
A bird's-eye view of the Alteogen headquarters and research building
A bird's-eye view of the Alteogen headquarters and research building · Korea Economic Daily

Detailed summary

South Korea's Alteogen Inc. has cleared a major US patent hurdle after its partner Merck & Co. prevailed in all 14 challenges against rival Halozyme Therap ...

Read the full article on Korea Economic Daily Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.kedglobal.com)

Also worth reading